Dr. J. De Sutter
Board
1 director, last change in 2022Statutory director
since 01-05-2006
earlier statutory manager, until 05-10-2022
also on the board of 1 other company
listed in the 2025 annual accounts, filed on 30-06-2026
- Signing authorityThe articles say who may bind the company, for example by signing a contract.
- “Iedere bestuurder vertegenwoordigt de vennootschap jegens derden en in rechte als eiser of als verweerder.”deed of 26-10-2022
Mandates through the years
1 name, the dashed line is todayStatutory director
BoardEarliermandate already running before its first mention
Mandates as a list
-
- Statutory director, from 01-05-2006 to date
- Statutory manager, until 05-10-2022
With Starter you also see 1 former office holder in the mandate history.
See plans →
Control
Shareholder
This company
Dr. J. De Sutter
Equity €807,042
Profit €279,748 in 2025
Capital
- Contribution
- €12,400
- Shares
- 100 in the deed of 03-01-2014
- Source
- 2025 annual accounts
Articles of association
deed of 26-10-2022 (in Dutch)- DurationMost companies exist for an unlimited period, until they are dissolved.
- Unlimited
- Board ruleThese rules set how the board is made up, meets and takes decisions.
- At least 1 director
- Kind of sharesThe articles set which classes of shares exist and what rights each class carries.
- Register van aandelen op zetel, eenparigheid van stemmen door bestaande aandeelhouders
- Annual meetingThe shareholders approve the annual accounts, among other things, at the annual meeting.
- 1 June at 18:00
- Liquidation ruleIn a liquidation the creditors are paid first. What is left goes to the shareholders.
- Ontbinding en sluiting in een akte mits WVV-voorwaarden, bestuurder(s) in functie krachtens statuten indien geen andere benoemd
Shareholders
After the capital increase
deed of 03-01-2014 ↗
- €139,500 in cash
Stated in the deed
deed of 03-01-2014 ↗
- all shares
Capital transactions
Capital over time
- 26-10-2022 Converted to unavailable equity
- 29-12-2017 Capital reduction of €139,500 · to €18,600 · repaid to the shareholders
- 03-01-2014 Capital increase of €139,500 · to €158,100 · no new shares · in cash